May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
General Admission’s mix in May 2026 concentrated further in Pre-Roll at 65.38% share, while Vapor Pens held 32.48% and the long tail of Edible at 1.15% and Flower at 1.00% continued to contract. Pre-Roll posted a 5.33% month-over-month uptick against a -12.79% year-over-year decline, suggesting volume recovery within a still-lower annual base, whereas Vapor Pens fell -10.15% month-over-month despite a comparatively modest -2.30% year-over-year slide. Edible inched up 3.33% month-over-month but remained down -54.16% year-over-year, and Flower dropped -27.39% month-over-month with a -10.79% year-over-year decline. With brand sales down -10.58% year-over-year and average price up 7.25%, the pattern implies the brand leaned into price over volume, and the month-over-month rebound in Pre-Roll alongside a contraction in Vapor Pens indicates short-term reliance on Pre-Roll to stabilize share.
The category shift implies a positioning centered on Pre-Roll leadership, reinforced by a rank of 1 in Pre-Roll in Alberta, while Vapor Pens functions as a secondary pillar that is more exposed to monthly volatility. The 5.33% month-over-month gain in Pre-Roll versus the -10.15% month-over-month decline in Vapor Pens points to merchandising or supply emphasis that prioritizes Pre-Roll throughput, and the -12.79% year-over-year Pre-Roll decline versus the -2.30% year-over-year Vapor Pens decline signals that annual headwinds are heavier in the core than in the adjunct category. Given average price at $29.34 and Pre-Roll average price at $28.84, the price ladder remains tight, implying limited room for premiumization; combined with Edible at 1.15% share and Flower at 1.00% share, the mix suggests a focused, two-category strategy where sustaining rank and regaining volume efficiency in Pre-Roll is the primary path to reversing the -10.58% year-over-year brand sales contraction.
Competitive Landscape
General Admission sits at rank #2 in ON Pre-Roll for May 2026 after a year-over-year shift from #1, with a prior peak at #1 in December 2025 and stability at #2 over the last three months indicating a plateau rather than a rebound; meanwhile, Back Forty / Back 40 Cannabis moved upward from #3 to #1 year over year alongside a 66.8% YoY sales change, while Jeeter declined from #2 to #3 with a -48.4% YoY sales change, showing that leadership is being redistributed toward faster-growing incumbents. With Thumbs Up Brand ascending from #7 to #4 on 40.6% YoY sales growth and Claybourne Co. slipping from #4 to #5 with a -21.4% YoY decline, the directional gap around the #2 spot is tightening from below while softening above, implying General Admission’s trajectory points to sustained contention for #1 only if upside momentum is recaptured before further share migration consolidates at the top.

Notable Products
The single most notable movement in May 2026 is Tiger Blood Distillate Infused Pre-Roll 3-Pack (1.5g), which jumped +64.0% month over month to rank 2 while the 5-Pack variant rose +20.7% at rank 1, indicating trade-up and trial are coexisting rather than cannibalizing. In contrast, Tiger Blood Liquid Diamond Disposable (1g) slid -4.5% to rank 3 and the Liquid Diamond Cartridge (0.95g) declined -5.0% at rank 10, putting vapor pens behind pre-rolls on momentum and rank position. Six of the top ten are Pre-Roll SKUs, including new Hi-Fi Diamond 3-Packs debuting at ranks 7 and 8 with no prior baseline, while the Tiger Blood Distillate Infused Pre-Roll (1g) dipped -1.0% at rank 4 alongside a -1.7% move for Tiger Blood Chews at rank 9; combined, this concentration points to format-led share capture in multi-pack pre-rolls over single sticks and non-inhalables. The mix implies General Admission is consolidating around value-forward pre-roll multi-packs with premiumized infusions, using a growing Tiger Blood ladder to anchor traffic while vapor pens recede in relative priority despite over $0.68M in disposable sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







